A Study of PTS100 in Primary HCC Patients
NCT03447951
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Para-Toluenesulfonamide
Sponsor
Gongwin Biopharm Co., Ltd.